A Gene Expression Profile of the Myocardial Response to Clenbuterol

[1]  M. Yacoub,et al.  Chronic Treatment with Clenbuterol Modulates Endothelial Progenitor Cells and Circulating Factors in a Murine Model of Cardiomyopathy , 2009, Journal of cardiovascular translational research.

[2]  S. Harding,et al.  Effects of clenbuterol on contractility and Ca2+ homeostasis of isolated rat ventricular myocytes. , 2008, American journal of physiology. Heart and circulatory physiology.

[3]  R. Bache,et al.  Regulation of coronary blood flow during exercise. , 2008, Physiological reviews.

[4]  M. Yacoub,et al.  Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure , 2008, Cardiovascular research.

[5]  O H Frazier,et al.  Cardiac Improvement During Mechanical Circulatory Support: A Prospective Multicenter Study of the LVAD Working Group , 2007, Circulation.

[6]  M. Yacoub,et al.  Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. , 2006, European heart journal.

[7]  Magdi H Yacoub,et al.  Left ventricular assist device and drug therapy for the reversal of heart failure. , 2006, The New England journal of medicine.

[8]  S. Nattel,et al.  Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. , 2006, Genes & development.

[9]  Emilio Hirsch,et al.  Integrin signalling: the tug-of-war in heart hypertrophy. , 2006, Cardiovascular research.

[10]  P. Frenette,et al.  Signals from the Sympathetic Nervous System Regulate Hematopoietic Stem Cell Egress from Bone Marrow , 2006, Cell.

[11]  P. Barton,et al.  Real-time quantitative polymerase chain reaction in cardiac transplant research. , 2006, Methods in molecular biology.

[12]  A. Khaghani,et al.  Gene Profiling Changes in Cytoskeletal Proteins During Clinical Recovery After Left Ventricular–Assist Device Support , 2005, Circulation.

[13]  I. Shiojima,et al.  Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. , 2005, The Journal of clinical investigation.

[14]  G. Lanfranchi,et al.  Cardiac Overexpression of Melusin Protects From Dilated Cardiomyopathy Due to Long-Standing Pressure Overload , 2005, Circulation research.

[15]  D. Goldspink,et al.  beta2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle. , 2005, Journal of applied physiology.

[16]  S. Kong,et al.  Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats. , 2005, Physiological genomics.

[17]  M. Yacoub,et al.  Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle. , 2005, American journal of physiology. Heart and circulatory physiology.

[18]  P. Tukiainen,et al.  Double-blind cross-over comparison of clenbuterol and salbutamol tablets in asthmatic out-patients , 1975, European Journal of Clinical Pharmacology.

[19]  U. Ikeda,et al.  DNA microarray analysis of in vivo progression mechanism of heart failure. , 2003, Biochemical and biophysical research communications.

[20]  G. Dorn,et al.  Phenotyping hypertrophy: eschew obfuscation. , 2003, Circulation research.

[21]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[22]  S. Cherry,et al.  Cardiac Myocyte-Specific Excision of the &bgr;1 Integrin Gene Results in Myocardial Fibrosis and Cardiac Failure , 2002, Circulation research.

[23]  Robert J. Lefkowitz,et al.  Seven-transmembrane-spanning receptors and heart function , 2002, Nature.

[24]  M. Yacoub.  A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. , 2001, European heart journal.

[25]  E. Rubin,et al.  Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Myers,et al.  Left ventricular assist system as a bridge to myocardial recovery. , 1999, The Annals of thoracic surgery.

[27]  G. Mitchell,et al.  Measurement of heart rate and Q-T interval in the conscious mouse. , 1998, American journal of physiology. Heart and circulatory physiology.

[28]  K. Boheler,et al.  Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features. , 1998, Cardiovascular research.

[29]  K. Boheler,et al.  Pharmacological modulation of pressure-overload cardiac hypertrophy: changes in ventricular function, extracellular matrix, and gene expression. , 1997, Circulation.

[30]  K. Boheler,et al.  Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes. , 1995, Circulation.